Retrospective studies have linked opioid use with:

Retrospective studies have linked opioid use with:

• A. Increased risk of cancer recurrence; suppression of NK cell activity; ongoing trials
• B. Decreased risk of cancer recurrence
• C. No effect on recurrence
• D. Cure of cancer

Answer: (A)

Opioids can dampen immune function, notably reducing natural killer (NK) cell activity. NK cells are part of the body’s early defense against micrometastases and residual cancer cells after surgery. In retrospective studies of cancer patients, higher perioperative opioid exposure has been associated with an increased risk of cancer recurrence, which aligns with the idea that opioid-induced immune suppression could influence tumor spread. But these studies observe associations, not proof of causation, and results can be affected by confounding factors such as cancer stage, pain levels, surgical complexity, and adjuvant treatments. That’s why ongoing trials are needed to determine whether changing analgesic approaches around surgery actually changes recurrence outcomes. Other possibilities—decreased recurrence, no effect, or cure—aren’t supported by the current retrospective data, which point to a potential link between opioid use and higher recurrence risk via immune suppression, rather than strong evidence of benefit or cure.

Opioids can dampen immune function, notably reducing natural killer (NK) cell activity. NK cells are part of the body’s early defense against micrometastases and residual cancer cells after surgery. In retrospective studies of cancer patients, higher perioperative opioid exposure has been associated with an increased risk of cancer recurrence, which aligns with the idea that opioid-induced immune suppression could influence tumor spread. But these studies observe associations, not proof of causation, and results can be affected by confounding factors such as cancer stage, pain levels, surgical complexity, and adjuvant treatments. That’s why ongoing trials are needed to determine whether changing analgesic approaches around surgery actually changes recurrence outcomes. Other possibilities—decreased recurrence, no effect, or cure—aren’t supported by the current retrospective data, which point to a potential link between opioid use and higher recurrence risk via immune suppression, rather than strong evidence of benefit or cure.